Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

Published Ahead of Print

October 30, 2020

  • You have access
    11C-sorafenib and 15O-H2O PET for early evaluation of sorafenib therapy
    Lemonitsa H. Mammatas, Maqsood Yaqub, N. Harry Hendrikse, Otto S. Hoekstra, Richard J. Honeywell, Robert C. Schuit, Martijn R. Meijerink, Lothar A. Schwarte, Godefridus J. Peters, Henk M.W. Verheul, Adriaan A. Lammertsma and C. Willemien Menke-van der Houven van Oordt
    Journal of Nuclear Medicine October 30, 2020, jnumed.120.251611; DOI: https://doi.org/10.2967/jnumed.120.251611
  • You have access
    Comparison of CD38 targeted alpha- vs beta-radionuclide therapy of disseminated multiple myeloma in an animal model
    Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E Shively and Flavia Pichiorri
    Journal of Nuclear Medicine October 30, 2020, jnumed.120.251983; DOI: https://doi.org/10.2967/jnumed.120.251983
  • You have access
    Cyclotron produced 132La as a PET imaging surrogate of therapeutic 225Ac
    Eduardo Aluicio-Sarduy, Todd E. Barnhart, Jamey Weichert, Reinier Hernandez and Jonathan W. Engle
    Journal of Nuclear Medicine October 30, 2020, jnumed.120.255794; DOI: https://doi.org/10.2967/jnumed.120.255794
  • You have access
    Letter to the Editor: “Disparities in PET imaging for prostate cancer at a tertiary academic medical center”
    Benjamin Lewis Franc and Andrei Iagaru
    Journal of Nuclear Medicine October 30, 2020, jnumed.120.258160; DOI: https://doi.org/10.2967/jnumed.120.258160
  • You have access
    Reply to LTE: Automated segmentation of TMTV in DLBCL patients: what about method measurement uncertainty?
    Sally Barrington, Ben GJC Zwezerijnen, Henrica CW de Vet, Martijn W Heymans and Ronald Boellaard
    Journal of Nuclear Medicine October 30, 2020, jnumed.120.257030; DOI: https://doi.org/10.2967/jnumed.120.257030
  • You have access
    Feasibility of single-time-point dosimetry for radiopharmaceutical therapies
    Xinchi Hou, Julia Brosch, Carlos Uribe, Alessandro Desy, Guido Boning, Jean-Mathieu Beauregard, Anna Celler and Arman Rahmim
    Journal of Nuclear Medicine October 30, 2020, jnumed.120.254656; DOI: https://doi.org/10.2967/jnumed.120.254656

October 23, 2020

  • You have access
    Performance evaluation of the uEXPLORER Total-body PET/CT scanner based on NEMA NU 2-2018 with additional tests to characterize long axial field-of-view PET scanners
    Benjamin A. Spencer, Eric Berg, Jeffrey P. Schmall, Negar Omidvari, Edwin K. Leung, Yasser G. Abdelhafez, Songsong Tang, Zilin Deng, Yun Dong, Yang Lv, Jun Bao, Weiping Liu, Hongdi Li, Terry Jones, Ramsey D. Badawi and Simon R. Cherry
    Journal of Nuclear Medicine October 23, 2020, jnumed.120.250597; DOI: https://doi.org/10.2967/jnumed.120.250597
  • You have access
    Impact of 68Ga-FAPI-PET/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas
    Manuel Röhrich, Patrick Naumann, Frederik Lars Giesel, Peter Choyke, Fabian Staudinger, Annika Wefers, Dawn P Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe A. Haberkorn, Matthias Lang and Stefan A. Koerber
    Journal of Nuclear Medicine October 23, 2020, jnumed.120.253062; DOI: https://doi.org/10.2967/jnumed.120.253062
  • You have access
    Imaging of the glucagon receptor in subjects with type 2 diabetes
    Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J Larsen, Jan-Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner and Michael Wagner
    Journal of Nuclear Medicine October 23, 2020, jnumed.118.213306; DOI: https://doi.org/10.2967/jnumed.118.213306
  • You have access
    Principal components analysis based measures of PET data closely reflect neuropathological staging schemes
    Ganna Blazhenets, Lars Frings, Arnd Sörensen and Philipp T Meyer
    Journal of Nuclear Medicine October 23, 2020, jnumed.120.252783; DOI: https://doi.org/10.2967/jnumed.120.252783
  • You have access
    Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with Copper-67
    Lachlan E. McInnes, Carleen Cullinane, Peter Roselt, Susan Jackson, Benjamin Blyth, Ellen van Dam, Nicholas A. Zia, Matthew J. Harris, Rodney J. Hicks and Paul S. Donnelly
    Journal of Nuclear Medicine October 23, 2020, jnumed.120.251579; DOI: https://doi.org/10.2967/jnumed.120.251579
  • You have access
    Optoacoustic imaging of Glucagon-like Peptide 1 Receptor with a near-infrared exendin-4 analog
    Sheryl Roberts, Eshita Khera, Crystal Choi, Tejas Navaratna, Jan Grimm, Greg M. Thurber and Thomas Reiner
    Journal of Nuclear Medicine October 23, 2020, jnumed.120.252262; DOI: https://doi.org/10.2967/jnumed.120.252262
  • You have access
    Absolute Quantitation of Cardiac 99mTc-pyrophosphate Using Cadmium Zinc Telluride-based SPECT/CT
    Sharmila Dorbala, Mi-Ae Park, Sarah Cuddy, Vasvi Singh, Kyle Sullivan, Sirwoo Kim, Rodney H Falk, Viviany Taqueti, Hicham Skali, Ron Blankstein, Camden Bay, Marie Foley Kijewski and Marcelo F. Di Carli
    Journal of Nuclear Medicine October 23, 2020, jnumed.120.247312; DOI: https://doi.org/10.2967/jnumed.120.247312

October 16, 2020

  • You have access
    Effects of Repeated 131I-meta-iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activities in Patients with Metastatic Neuroendocrine Tumors
    Keiichiro Yoshinaga, Takashige Abe, Shozo Okamoto, Yuko Uchiyama, Osamu Manabe, Yoichi M. Ito, Naomi Tamura, Natsue Ito, Naho Yoshioka, Komei Washino, Nobuo Shinohara, Nagara Tamaki and Tohru Shiga
    Journal of Nuclear Medicine October 16, 2020, jnumed.120.250803; DOI: https://doi.org/10.2967/jnumed.120.250803
  • Open Access
    Safety, biodistribution and radiation dosimetry of 18F-rhPSMA-7.3 in healthy adult volunteers
    Tuula Tolvanen, Kari K Kalliokoski, Simona Malaspina, Anna Kuisma, Salla Lahdenpohja, Ernst J Postema, Matthew P Miller and Mika Scheinin
    Journal of Nuclear Medicine October 16, 2020, jnumed.120.252114; DOI: https://doi.org/10.2967/jnumed.120.252114
  • You have access
    18F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy: a prospective 10-year follow-up study of 166 patients
    Tina Binderup, Ulrich Knigge, Camilla Bardram Johnbeck, Annika Loft, Anne Kiil Berthelsen, Peter Oturai, Jann Mortensen, Birgitte Federspiel, Seppo W Langer and Andreas Kjaer
    Journal of Nuclear Medicine October 16, 2020, jnumed.120.244798; DOI: https://doi.org/10.2967/jnumed.120.244798

October 9, 2020

  • You have access
    Automated segmentation of TMTV in DLBCL patients: what about method measurement uncertainty?
    Eric Laffon and Roger Marthan
    Journal of Nuclear Medicine October 9, 2020, jnumed.120.256214; DOI: https://doi.org/10.2967/jnumed.120.256214
  • You have access
    Sentinel Lymph Node Biopsy in breast cancer with 99mTc-Tilmanocept: A novel tracer in the real life. A multicenter study
    Sergi Vidal-Sicart, María Eugenia Rioja, Andrea Prieto, Elena Goñi, Isabel Gómez, María Dolores Albala, Luis Lumbreras, Luisa Fernanda León, José Ramón Gómez and Francisco Campos
    Journal of Nuclear Medicine October 9, 2020, jnumed.120.252064; DOI: https://doi.org/10.2967/jnumed.120.252064
  • You have access
    Dose optimization in pediatric studies: Why this is important and can benefit every nuclear medicine department
    John O. Prior, Siroos Mirzaei, Silvano Gnesin and Marie Nicod Lalonde
    Journal of Nuclear Medicine October 9, 2020, jnumed.120.254193; DOI: https://doi.org/10.2967/jnumed.120.254193
  • You have access
    Measurement of PET Quantitative Bias In Vivo
    Martin A Lodge, Wojciech Lesniak, Michael A. Gorin, Kenneth J Pienta, Steven P. Rowe and Martin G. Pomper
    Journal of Nuclear Medicine October 9, 2020, jnumed.120.251397; DOI: https://doi.org/10.2967/jnumed.120.251397
  • You have access
    18F-FLT-PET/CT adds value to 18F-FDG-PET/CT for diagnosing relapse after definitive radiotherapy in patients with lung cancer. Results of a prospective clinical trial
    Tine Noehr Christensen, Seppo W Langer, Gitte F Persson, Klaus Richter Larsen, Annika Loft, Annemarie Gjelstrup Amtoft, Anne Kiil Berthelsen, Helle Hjorth Johannesen, Sune Hoegild Keller, Andreas Kjaer and Barbara Malene Fischer
    Journal of Nuclear Medicine October 9, 2020, jnumed.120.247742; DOI: https://doi.org/10.2967/jnumed.120.247742
  • You have access
    Repeatability of Radiomic Features of Brown Adipose Tissue
    Aria Nazeri, John P Crandall, Tyler J Fraum and Richard L. Wahl
    Journal of Nuclear Medicine October 9, 2020, jnumed.120.248674; DOI: https://doi.org/10.2967/jnumed.120.248674
  • You have access
    PET/MRI versus PET/CT for Whole-Body Staging
    Stephen K Gerard
    Journal of Nuclear Medicine October 9, 2020, jnumed.120.256453; DOI: https://doi.org/10.2967/jnumed.120.256453

October 2, 2020

  • You have access
    Prognostic value of 16α-[18F]-fluoro-17β-estradiol positron emission tomography as a predictor of disease outcome in endometrial cancer: A prospective study
    Shizuka Yamada, Hideaki Tsuyoshi, Makoto Yamamoto, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa and Yoshio Yoshida
    Journal of Nuclear Medicine October 2, 2020, jnumed.120.244319; DOI: https://doi.org/10.2967/jnumed.120.244319
  • You have access
    Repeatability of 18F-FDG PET Radiomic Features in Cervical Cancer
    John P Crandall, Tyler J Fraum, MinYoung Lee, Linda Jiang, Perry W. Grigsby and Richard L. Wahl
    Journal of Nuclear Medicine October 2, 2020, jnumed.120.247999; DOI: https://doi.org/10.2967/jnumed.120.247999
  • You have access
    Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer using an anti-EGFR Antibody-Dye Conjugate
    Naoki Nishio, Nynke S. van den Berg, Brock A Martin, Stan van Keulen, Shayan Fakurnejad, Eben L Rosenthal and Katheryne E Wilson
    Journal of Nuclear Medicine October 2, 2020, jnumed.120.245241; DOI: https://doi.org/10.2967/jnumed.120.245241
  • You have access
    First clinical results for PSMA targeted alpha therapy using 225Ac-PSMA-I&T in advanced mCRPC patients
    Mathias Johannes Zacherl, Franz Josef Gildehaus, Lena Mittlmeier, Guido Boening, Astrid Gosewisch, Vera Wenter, Nina-Sophie Schmidt-Hegemann, Claus Belka, Alexander Kretschmer, Jozefina Casuscelli, Christian G. Stief, Marcus Unterrainer, Peter Bartenstein, Andrei Todica and Harun Ilhan
    Journal of Nuclear Medicine October 2, 2020, jnumed.120.251017; DOI: https://doi.org/10.2967/jnumed.120.251017
  • You have access
    The role of nuclear medicine in the clinical management of benign thyroid disorders. Part 1. Hyperthyroidism
    Giuliano Mariani, Massimo Tonacchera, Mariano Grosso, Francesca Orsolini, Paolo Vitti and H. William Strauss
    Journal of Nuclear Medicine October 2, 2020, jnumed.120.243170; DOI: https://doi.org/10.2967/jnumed.120.243170

September 25, 2020

  • You have access
    Disparities in PET imaging for prostate cancer at a tertiary academic medical center
    Matthew D. Bucknor, Daphne Y. Lichtensztajn, Tracy K. Lin, Hala T. Borno, Scarlett L. Gomez and Thomas A. Hope
    Journal of Nuclear Medicine September 25, 2020, jnumed.120.251751; DOI: https://doi.org/10.2967/jnumed.120.251751
  • You have access
    Repurposing [11C]PS13 for PET imaging of cyclooxygenase-1 (COX-1) in ovarian cancer xenograft mouse models
    Amanda Jean Boyle, Junchao Tong, Sami Zoghbi, Victor W. Pike, Robert Innis and Neil Vasdev
    Journal of Nuclear Medicine September 25, 2020, jnumed.120.249367; DOI: https://doi.org/10.2967/jnumed.120.249367
  • You have access
    PET Imaging Reveals Early Pulmonary Perfusion Abnormalities in HIV Infection Similar to Smoking
    Puja Kohli, Vanessa J. Kelly, Kathryn A. Hibbert, Björn Corleis, Mamary Kone, Josalyn L. Cho, Doreen Defaria-Yeh, Douglas S. Kwon, Benjamin D. Medoff, R. Scott Harris and Tilo Winkler
    Journal of Nuclear Medicine September 25, 2020, jnumed.120.245977; DOI: https://doi.org/10.2967/jnumed.120.245977

September 18, 2020

  • You have access
    Total-Body Quantitative Parametric Imaging of Early Kinetics of FDG
    Tao Feng, Yizhang Zhao, Hongcheng Shi, Xuezhu Zhang, Guobao Wang, Ramsey Derek Badawi, Patricia M Price, Simon R. Cherry and TERRY JONES
    Journal of Nuclear Medicine September 18, 2020, jnumed.119.238113; DOI: https://doi.org/10.2967/jnumed.119.238113
  • You have access
    Clinical utility of 18F-FDG PET/CT in staging and treatment planning of urachal adenocarcinoma
    Jeeban P Das, Hebert Alberto Vargas, Soleen Ghafoor, Alvin C Goh and Gary A Ulaner
    Journal of Nuclear Medicine September 18, 2020, jnumed.120.251561; DOI: https://doi.org/10.2967/jnumed.120.251561

September 11, 2020

  • You have access
    89Zr Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
    Kyung-Ho Jung, Jin Won Park, Jin Hee Lee, Eun Ji Lee, Seung Hwan Moon, Young Seok Cho and Kyung-Han Lee
    Journal of Nuclear Medicine September 11, 2020, jnumed.120.250720; DOI: https://doi.org/10.2967/jnumed.120.250720
  • You have access
    PSMA-PET identifies PCWG3 target populations with superior accuracy and reproducibility when compared to conventional imaging: a multicenter retrospective study
    Andrea Farolfi, Nader Hirmas, Andrei Gafita, Manuel Weber, Francesco Barbato, Axel Wetter, Riccardo Mei, Davide Pianori, Boris Hadaschik, Ken Herrmann, Paolo Castellucci, Stefano Fanti, Matthias Eiber and Wolfgang P Fendler
    Journal of Nuclear Medicine September 11, 2020, jnumed.120.246603; DOI: https://doi.org/10.2967/jnumed.120.246603

September 4, 2020

  • You have access
    Surveillance of clinically complete responders using serial 18F-FDG PET/CT scans in patients with esophageal cancer after neoadjuvant chemoradiotherapy
    Maria J. Valkema, Berend J. van der Wilk, Ben M. Eyck, Bas P.L. Wijnhoven, Manon C.W. Spaander, Michail Doukas, Sjoerd M. Lagarde, Wendy M.J. Schreurs, Mark J. Roef, J. Jan B. van Lanschot and Roelf Valkema
    Journal of Nuclear Medicine September 4, 2020, jnumed.120.247981; DOI: https://doi.org/10.2967/jnumed.120.247981
  • You have access
    Treatment Monitoring of Immunotherapy and Targeted Therapy using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
    Norbert Galldiks, Diana SY Abdulla, Matthias Scheffler, Fabian Wolpert, Jan-Michael Werner, Martin W Huellner, Gabriele Stoffels, Viola Schweinsberg, Max Schlaak, Nicole Kreuzberg, Jennifer Landsberg, Philipp Lohmann, Garry Ceccon, Christian Baues, Maike Trommer, Eren Celik, Maximilian I Ruge, Martin Kocher, Simone Marnitz, Gereon R Fink, Joerg-Christian Tonn, Michael Weller, Karl-Josef Langen, Jürgen Wolf and Cornelia Mauch
    Journal of Nuclear Medicine September 4, 2020, jnumed.120.248278; DOI: https://doi.org/10.2967/jnumed.120.248278
  • You have access
    The synthesis and structural requirements for measuring glucocorticoid receptor expression in vivo with (±)-11C-YJH08 PET
    Yangjie Huang, Ning Zhao, Yung-hua Wang, Charles Truillet, Junnian Wei, Matthew F.L. Parker, Joseph E. Blecha, Christopher R. Drake, Henry F. VanBrocklin, Diego G. Ruiz, Matthew P. Jacobson, Rahul Aggarwal, Spencer C. Behr, Robert R. Flavell, David M. Wilson, Youngho Seo and Michael J. Evans
    Journal of Nuclear Medicine September 4, 2020, jnumed.120.249755; DOI: https://doi.org/10.2967/jnumed.120.249755

August 28, 2020

  • You have access
    Developing and implementing an imaging optimization study in pediatric nuclear medicine: Experience and recommendations from an IAEA Coordinated Research Project
    Gian Luca Poli, Marco Antonio Coca, Leonel Alberto Torres, Frederic H Fahey, Michael H Lassmann, Claire-Louise Chapple, Peter Homolka and Harry Delis
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.244616; DOI: https://doi.org/10.2967/jnumed.120.244616
  • You have access
    Novel 177Lu-labeled Albumin-binder-conjugated PSMA-targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-kidney Absorbed Dose Ratio
    Hsiou-Ting Kuo, Kuo-Shyan Lin, Zhengxing Zhang, Carlos F Uribe, Helen Merkens, Chengcheng Zhang and Francois Benard
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.250738; DOI: https://doi.org/10.2967/jnumed.120.250738
  • You have access
    Somatostatin receptor-targeted radiopeptide therapy in treatment-refractory meningioma: an individual patient data meta-analysis
    Christian Mirian, Anne Katrine Duun-Henriksen, Andrea Daniela Maier, Maria Møller Pedersen, Lasse Rehné Jensen, Asma Bashir, Thomas Graillon, Maya Hrachova, Daniela Bota, Martjin van Essen, Petar Spanjol, Christian Kreis, Ian Law, Helle Broholm, Lars Poulsgaard, Kåre Fugleholm, Morten Ziebell, Tina Munch, Martin A. Walter and Tiit Mathiesen
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.249607; DOI: https://doi.org/10.2967/jnumed.120.249607
  • You have access
    Dopaminergic nigrostriatal connectivity in early Parkinson disease: in vivo neuroimaging study of 11C-DTBZ PET combined with correlational tractography.
    Carlos Alfredo Sanchez-Catasus, Nicolaas I Bohnen, Fang-Cheng Yeh, Nicholas D'Cruz, Prabesh Kanel and Martijn L.T.M. Muller
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.248500; DOI: https://doi.org/10.2967/jnumed.120.248500
  • Open Access
    Quantification of macrophage-driven inflammation during myocardial infarction with 18F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism
    Mark G. MacAskill, Agne Stadulyte, Lewis Williams, Timaeus E. F. Morgan, Nikki L. Sloan, Carlos J. Alcaide-Corral, Tashfeen Walton, Catriona Wimberley, Chris-Anne McKenzie, Nick B. Spath, William Mungall, Ralph BouHaidar, Marc R. Dweck, Gillian A. Gray, David E. Newby, Christophe Lucatelli, Andrew Sutherland, Sally Pimlott and Adriana A. S. Tavares
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.243600; DOI: https://doi.org/10.2967/jnumed.120.243600
  • You have access
    First experience using F-18-flubrobenguane PET imaging in patients with the suspicion of pheochromocytoma or paraganglioma
    Lukas Kessler, Anna Melissa Schlitter, Markus Kroenke, Alexander von Werder, Robert Tauber, Tobias Maurer, Simon P Robinson, Cesare Orlandi, Michael Herz, Behrooz H Yousefi, Stephan G. Nekolla, Markus Schwaiger, Matthias Eiber and Christoph Rischpler
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.248021; DOI: https://doi.org/10.2967/jnumed.120.248021
  • Open Access
    First-in-Human Study of 68Ga-DOTA-Siglec-9, PET Ligand Targeting Vascular Adhesion Protein 1
    Riikka Viitanen, Olli Antero Moisio, Petteri Lankinen, Xiang-Guo Li, Mikko Koivumäki, Sami Suilamo, Tuula Tolvanen, Kirsi Taimen, Markku Mali, Ia Kohonen, Ilpo Koskivirta, Vesa Oikonen, Helena Virtanen, Kristiina Santalahti, Anu Autio, Antti Saraste, Laura Pirilä, Pirjo Nuutila, Juhani Knuuti, Sirpa Jalkanen and Anne Roivainen
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.250696; DOI: https://doi.org/10.2967/jnumed.120.250696
  • You have access
    Deep learning generation of synthetic intermediate projections improves 177Lu SPECT images reconstructed with sparsely acquired projections
    Tobias Ryden, Martijn van Essen, Ida Marin, Johanna Svensson and Peter Bernhardt
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.245548; DOI: https://doi.org/10.2967/jnumed.120.245548
  • You have access
    Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer – Results from a Prospective Imaging Trial
    Nils H Nicolay, Alexander Rühle, Nicole Wiedenmann, Gabriele Niedermann, Michael Mix, Wolfgang Andreas Weber, Dimos Baltas, Martin Werner, Gian Kayser and Anca L Grosu
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.248633; DOI: https://doi.org/10.2967/jnumed.120.248633
  • You have access
    First in Human Assessment of the Novel M1 Muscarinic Acetylcholine Receptor PET Radiotracer 11C-LSN3172176
    Mika Naganawa, Nabeel B Nabulsi, Shannan Henry, David Matuskey, Shu-fei Lin, Lawrence Slieker, Adam J. Schwarz, Nancy Kant, Cynthia Jesudason, Kevin Ruley, Antonio Navarro, Hong Gao, Jim Ropchan, David Labaree, Richard E. Carson and Yiyun Huang
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.246967; DOI: https://doi.org/10.2967/jnumed.120.246967
  • You have access
    Longitudinal molecular imaging of progesterone receptor reveals early differential response to endocrine therapy in breast cancer with an activating ESR1 mutation
    Manoj Kumar, Kelley Salem, Justin J Jeffery, Yongjun Yan, Aparna M Mahajan and Amy M Fowler
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.249508; DOI: https://doi.org/10.2967/jnumed.120.249508
  • You have access
    First-in-human evaluation of 18F-SynVesT-1, a novel radioligand for PET imaging of synaptic vesicle protein 2A
    Mika Naganawa, Songye Li, Nabeel B Nabulsi, Shannan Henry, Ming-Qiang Zheng, Richard Pracitto, Zhengxin Cai, Hong Gao, Michael Kapinos, David Labaree, David Matuskey, Yiyun Huang and Richard E. Carson
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.249144; DOI: https://doi.org/10.2967/jnumed.120.249144

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire